Publication date: Jul 21, 2025
Less Inflammation, Higher Performance With these encouraging signs of reduced inflammation, the researchers next tested whether the new lipids also improved vaccine performance. The new lipids also gave cancer-fighting T cells a boost, helping them recognize and destroy tumor cells more efficiently — and with less oxidative stress. By checking various markers associated with oxidative stress, the researchers compared the inflammatory effects of LNPs formulated using different lipids. Finally, when the team used the C-a16 lipids for preparing COVID-19 mRNA vaccines, the immune response in animal models was five times stronger than with standard formulations. “By causing less disruption to cellular machinery, the new, phenol-containing lipids can enhance a wide range of LNP applications,” says Kim. The C-a16 lipids also helped gene-editing tools like CRISPR do a better job fixing the faulty gene that causes hATTR. C-a16 LNPs not only produced longer-lasting effects, but also improved the efficacy of gene-editing tools like CRISPR and the potency of vaccines for treating cancer.

| Concepts | Keywords |
|---|---|
| Cancer | A16 |
| Fireflies | Covid |
| Sandwich | Engineering |
| Smarter | Found |
| Tr002776 | Inflammation |
| Lipid | |
| Lipids | |
| Lnps | |
| Mitchell | |
| Mrna | |
| Phenol | |
| Reaction | |
| Vaccines |
Semantics
| Type | Source | Name |
|---|---|---|
| disease | IDO | immune response |
| pathway | KEGG | Melanoma |
| disease | MESH | melanoma |
| disease | MESH | hereditary transthyretin amyloidosis |
| disease | MESH | liver disease |
| disease | MESH | causes |
| drug | DRUGBANK | Oxygen |
| drug | DRUGBANK | (S)-Des-Me-Ampa |
| disease | MESH | Genetic Disease |
| disease | MESH | oxidative stress |
| drug | DRUGBANK | Activated charcoal |
| disease | IDO | history |
| drug | DRUGBANK | Olive oil |
| drug | DRUGBANK | Tropicamide |
| drug | DRUGBANK | Phenol |
| disease | MESH | cancer |
| disease | MESH | inflammation |
| disease | MESH | COVID-19 |